Efficacy and safety of reslizumab in adjuvant therapy for patients with refractory asthma: a meta-analysis

Chen Manru, Liang Cuilyu, Zhang Yin, Chen Qiying, Chen Caiyun

PDF(5814 KB)
PDF(5814 KB)
Adverse Drug Reactions Journal ›› 2023, Vol. 25 ›› Issue (5) : 299-307. DOI: 10.3760/cma.j.cn114015-20220824-00774

Efficacy and safety of reslizumab in adjuvant therapy for patients with refractory asthma: a meta-analysis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 25(5): 299-307 https://doi.org/10.3760/cma.j.cn114015-20220824-00774

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(5814 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉